Your session is about to expire
← Back to Search
Easytech Reversed Shoulder System for Shoulder Osteoarthritis
Study Summary
This trial is testing a new shoulder replacement system to see if it is safe and effective.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My bones are too weak to support an implant.I have a fracture in my shoulder area.I currently have active cancer.I have had fractures from minor injuries.My shoulder muscle works normally.My shoulder muscle works normally.I do not have an active infection or a history of joint infection in my shoulder.I have a bone condition like osteoporosis or Paget's disease.I have a severe, unfixable tear in my shoulder tendon.I need my hands to stand up from a sitting position.I have not taken more than 5mg/day of corticosteroids, except inhalers, in the last 3 months.I have a severe injury or disease affecting my upper arm's nerves.My body is suitable for implants as determined by surgical tests.I have circulation problems like blood clots or swollen limbs.I am 21 years old or older.I can follow the study's schedule and tests.My bones have fully grown, including in my shoulder area.I need shoulder replacement surgery due to arthritis or bone death.I have a severe shoulder injury that cannot be surgically repaired.
- Group 1: Easytech group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What goals has this experiment been designed to achieve?
"This 24-month clinical trial aims to determine whether the humeral component has subsided or migrated more than 5mm. Evaluative metrics include patient responses on function and pain (ASES), range of motion in forward and lateral elevation, internal/external rotation arm at side (ROM) as well as QuickDASH scores that measure the ability to complete tasks, absorb forces and symptom severity."
Is this trial currently recruiting participants?
"According to clinicaltrials.gov, this research study is not actively recruiting participants at the moment; it was first posted on November 28th 2018 and last edited on June 20th 2022. However, there are currently 768 other trials openly accepting patients for enrollment."
How many sites are overseeing this research project?
"Currently, 6 sites are participating in this investigation - Orthopedics Rhode island (Wakefield), Texas Orthopaedic Specialists (Bedford) and The CORE Institute (Sun City West). There are also three additional medical facilities enrolled."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What questions have other patients asked about this trial?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger